KD Logo

Examining the Potential Price Growth of Quest Diagnostics, Inc (DGX)

Quest Diagnostics, Inc’s recently made public that its SVP & Chief Commercial Officer DELANEY MARK E unloaded Company’s shares for reported $0.15 million on May 12 ’25. In the deal valued at $175.72 per share,874 shares were sold. As a result of this transaction, DELANEY MARK E now holds 8,372 shares worth roughly $1.49 million.

Then, DELANEY MARK E sold 874 shares, generating $153,221 in total proceeds. Upon selling the shares at $175.31, the SVP & Chief Commercial Officer now owns 7,498 shares.

Before that, DELANEY MARK E bought 874 shares. Quest Diagnostics, Inc shares valued at $153,221 were divested by the Officer at a price of $175.31 per share.

Redburn Atlantic initiated its Quest Diagnostics, Inc [DGX] rating to a Buy in a research note published on April 02, 2025; the price target was $195. A number of analysts have revised their coverage, including Citigroup’s analysts, who decreased its forecast for the stock in early March from “a Buy” to “a Neutral”. Leerink Partners also remained covering DGX and has increased its forecast on January 06, 2025 with a “an Outperform” recommendation from previously “Market perform” rating. Morgan Stanley revised its rating on December 17, 2024. It rated DGX as “an Overweight” which previously was an “an Equal-weight”.

Price Performance Review of DGX

On Friday, Quest Diagnostics, Inc [NYSE:DGX] saw its stock jump 0.88% to $177.97. Over the last five days, the stock has gained 0.57%. Quest Diagnostics, Inc shares have risen nearly 17.97% since the year began. Nevertheless, the stocks have risen 27.89% over the past one year. While a 52-week high of $179.32 was reached on 05/02/25, a 52-week low of $135.47 was recorded on 01/16/25. SMA at 50 days reached $170.61, while 200 days put it at $160.13.

Levels Of Support And Resistance For DGX Stock

The 24-hour chart illustrates a support level at 176.36, which if violated will result in even more drops to 174.74. On the upside, there is a resistance level at 178.91. A further resistance level may holdings at 179.84. The Relative Strength Index (RSI) on the 14-day chart is 59.24, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.98, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bullish at 16.98%. Stochastics %K at 53.46% indicates the stock is a holding.

Most Popular